Global Cryoablation Market Research Report 2018-2023
Summary – A new market study, “Global Cryoablation Market Research and Forecast, 2018-2023 ”has been featured on WiseGuyReports.
Cryoablation is a technology used to destroy
the abnormal cells or tissues using cryoprobe and cryogen agents. Cryoablation
therapy is emerging as an alternative for the treatment of various chronic
diseases such as lung cancer, renal tumor, and prostate cancer and so on. The
change in lifestyles such as the consumption of alcohol and tobacco are leading
to an increasing prevalence of chronic diseases which can drive the adoption of
cryoablation therapy in various hospitals and clinics. Moreover, the least risk
of stroke making it more effective.
However, the lack of qualified/skilled medical
practitioner and a high cost of treatment are the major challenges for the
industry. The factors favoring the growth of the global cryonic market include the
adoption of minimally invasive technology and R&D activities in
cryoablation treatment. The increased application of this therapy will turn out
to be a huge opportunity for this market.
Geographically market is divided into North
America, Europe, Asia Pacific and Rest of the World. North America is expected
to be dominating in the global cryoablation market due to the developed
healthcare system and the increasing healthcare expenditure. In addition, the
prevalence of cancer in the US contribute to the growth of this region.
According to the National Cancer Institute, the number of diagnosed cases in
the US in 2016 was 1,685,210. The cryoablation devices is a preferred treatment
for cancer as it effectively reduces the growth of targeted cells. APAC is
projected to be an emerging market for this technology. The increase in
awareness of such technology is a key attributor for the growth of the market
in the APAC region.
There are various companies who are involved in
cryoablation business such as HealthTronics, Inc, Cooper Surgical Inc,
AtriCure, Inc., Galil Medical Inc., Endocare, Inc., Integra LifeSciences
Holdings Corporation and so on. The companies are mainly focusing on investing
in cryoablation devices and equipment, expansion of market share and also
research and development of such technologies. Merger and acquisition are the
major strategies adopted by most of the market players. For an instance: Boston
Scientific has signed an agreement in July 2018 for the acquisition of a
cryoablation platform developer, Cryterion Medical.
Research Methodology
The market study of Cryoablation market is
incorporated by extensive primary and secondary research conducted by the
research team at OMR. Secondary research has been conducted to refine the
available data to breakdown the market in various segments, derive total market
size, market forecast and growth rate. Different approaches have been worked on
to derive the market value and market growth rate. Our team collects facts and
data related to the market from different geography to provide a better
regional outlook. In the report, country-level analysis is provided by
analyzing various regional players, regional tax laws and policies, consumer
behavior and macroeconomic factors. Numbers extracted from Secondary research
have been authenticated by conducting proper primary research. It includes
tracking down key people from the industry and interviewing them to validate
the data. This enables our analyst to derive the closest possible figures
without any major deviations in the actual number. Our analysts try to contact
as many executives, managers, key opinion leaders and industry experts. Primary
research brings the authenticity in our reports.
Secondary sources include:
• Financial reports of companies involved in the
market
• Authentic Public Databases such as the
University of Arizona Cancer Center, WHO and others
• Whitepapers, research-papers and news blogs
• Company websites and their product catalog.
The Report is intended for Cryoablation device
manufacturer, cryogen agent producer, Investing companies, Government
Organizations for overall market analysis and competitive analysis. The report
provides an in-depth analysis of pricing, market size, intended quality of the
product preferred by consumers. The report will serve as a source for
360-degree analysis of the market thoroughly delivering insights into the
market for better business decisions.
Market Segmentation:
Global Cryoablation market is segmented on the
basis of regional outlook and following segments:
1. Global Cryoablation Market Research and
Analysis, By Application
2. Global Cryoablation Market Research and
Analysis, By Product
3. Global Cryoablation Market Research and
Analysis, By End User
The Report covers:
• Comprehensive research methodology of Global
Cryoablation
• This report also includes a detailed and
extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro
factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other
government policies impacting the
• Global Cryoablation Market.
• Insights about market determinants which are
stimulating the Global Cryoablation
• Detailed and extensive market segments with
regional distribution of forecasted revenues.
• Extensive profiles and recent developments of
market players.
Companies Mentioned
1. Adagio Medical, Inc.
2. Afreeze GmbH
3. Arrinex, Inc.
4. AtriCure, Inc.
5. ATS Medical, Inc.
6. BioSig Technologies, Inc.
7. Biotronik, Inc.
8. Boston Scientific Corporation
9. BTG plc
10. BVM Medical Ltd
11. C2 Therapeutics, Inc.
12. CooperSurgical Inc.
13. Endocare, Inc.
14. ERBE Elektromedizin GmbH
15. Galil Medical Inc
16. HealthTronics, Inc.
17. IceCure Medical Ltd
18. Integra LifeSciences Holdings Corporation
19. Medtronic plc
20. Sanarus Technologies, Inc
About Us:
Wise Guy Reports is part of the Wise Guy Research
Consultants Pvt. Ltd. and offers premium progressive
statistical surveying, market research reports, analysis
& forecast data for industries and governments
around the globe.
Contact Us:
NORAH
TRENT
sales@wiseguyreports.com
Ph: +162-825-80070
(US)
Ph: +44 2035002763 (UK)
Comments
Post a Comment